Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose

Vaccine

Volumn 31, Issue 15, 2013, Pages 1981-1986

  Vermeulen, Françoise ^a   Dirix, Violette ^a   Verscheure, Virginie ^a   Damis, Eliane ^c,g   Vermeylen, Danièle ^a   Locht, Camille ^d,e,f   Mascart, Françoise ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Centre Hospitalier Inter Régional Edith Cavell in Brussels   (Belgium)

^d INSERM U1019   (France)

^e CNRS   (France)

^f UNIV LILLE   (France)

^g BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Interferon gamma; Interleukin 5; Pertussis vaccines; Preterm infants

Indexed keywords

BACTERIAL ANTIGEN; BORDETELLA PERTUSSIS ANTIGEN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INFRARIX HEXA; INTERLEUKIN 5; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; PERTUSSIS; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; TH1 TH2 BALANCE; TH2 CELL;

ANTIGENS, BACTERIAL; BELGIUM; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERFERON-GAMMA; INTERLEUKIN-5; MALE; PERTUSSIS VACCINE; POLIOVIRUS VACCINE, INACTIVATED; TIME FACTORS; VACCINATION; VACCINES, ACELLULAR; VACCINES, COMBINED; WHOOPING COUGH;

EID: 84875242762     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.004     Document Type: Article

References (33)

1. Roberton D.M., Marshall H., Dinan L., Boros C., Gold M. Developmental immunology and vaccines: immune responses to vaccines in premature infants. Exp Rev Vaccines 2004, 3(4):343-347.
2. Crespo M., Martinez D.G., Cerissi A., Rivera-Reyes B., Bernstein H.B., Lederman M.M., et al. Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity. Pediatr Res 2012, 71(2):136-143.
3. Saari T.N., Committee on Infectious Diseases Immunization of preterm and low birth weight infants. Pediatrics 2003, 112(1):193-198.
4. Kirmani K.I., Lofthus G., Pichichero M.E., Voloshen T., D'Angio C.T. Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics 2002, 109(3):498-504.
5. Slack M.H., Cade A., Schapira D., Thwaites R.J., Crowley-Luke A., Southern J., et al. DT5aP-Hib-IPV and MCC vaccines: preterm infants response to accelerated immunization. Arch Dis Child 2005, 90:338-341.
6. Ad Hoc Group for the Study of Pertussis Vaccines Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events. Lancet 1988, 1(8592):955-960.
7. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996, 334(6):349-355.
8. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996, 334(6):341-348.
9. Feunou P.F., Bertout J., Locht C. T.- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS ONE 2010, 5(4):e10178.
10. Mahon B.P., Brady M.T., Mills K.H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J Infect Dis 2000, 181(6):2087-2091.
11. Mills K.H., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993, 61(2):399-410.
12. Ryan M., Murphy G., Ryan E., Nilsson L., Shackley F., Gothefors L., et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998, 93(1):1-10.
13. + lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults. Clin Dev Immunol 2012, 2012:795958.
14. Mascart F., Verscheure V., Malfroot A., Hainaut M., Piérard D., Temerman S., et al. Bordetella pertussis infection in 2-month-old infants promotes type 1T cell responses. J Immunol 2003, 170(3):1504-1509.
15. Cassone A., Ausiello C.M., Urbani F., Laude R., Giuliano M., La Sola A., et al. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch Pediatr Adolesc Med 1997, 151:283-289.
16. Ausiello C.M., Lande R., Urbani F., La Sala A., Stefanelli P., Salamaso S., et al. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun 1999, 67:4064-4067.
17. Vermeulen F., Verscheure V., Damis E., Vermeylen D., Leloux G., Dirix V., et al. Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines. Clin Vaccine Immunol 2010, 17(2):258-262.
18. Dirix V., Verscheure V., Goetghebuer T., Hainaut M., Debrie A-S., Locht C., et al. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Vaccine 2009, 27(43):6042-6047.
19. Omeñaca F., Garcia-Sicilia J., Boceta R., Sistiaga-Hernando A., García-Corbeira P. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely. Pediatr Infect Dis J 2007, 26(9):824-829.
20. Vázquez L., Garcia F., Rüttimann R., Coconier G., Jacquet J-M., Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr 2008, 97(9):1243-1249.
21. Antoine R., Locht C. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect Immun 1990, 58(6):1518-1526.
22. Menozzi F.D., Gantiez C., Locht C. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin. FEMS Microbiol Lett 1991, 78(1):59-64.
23. Alonso S., Pethe K., Mielcarek N., Raze D., Locht C. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection. Infect Immun 2001, 69(10):6038-6043.
24. Auerbach B.S., Lake A.M., Wilson M.E., Willingham F.F., Shematek J., Moulton L., et al. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine. Biologicals 1998, 26(2):145-153.
25. Faldella G., Alessandroni R., Magini G.M., Perrone A., Sabatini M.R., Vancini A., et al. The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine 1998, 16(17):1646-1649.
26. Schloesser R.L., Fischer D., Otto W., Rettwitz-Volk W., Herden P., Zielen S. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 1999, 103(5):e60.
27. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). Pediatrics 1999;103:1064-77.
28. Zepp F., Schmitt H-J., Cleerbout J., Verstraeten T., Schuerman L., Jacquet L-M. Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine). Exp Rev Vaccines 2009, 8(6):663-678.
29. Poolman J.T., Hallander H.O. Acellular pertussis vaccines and the role of pertactin and fimbriae. Exp Rev Vaccines 2007, 6(1):47-56.
30. White O.J., Rowe J., Richmond P., Marshall H., McIntyre P., Wood N., et al. Th2-polarisation of cellular immune memory to neonatal vaccination. Vaccine 2010, 28:2648-2652.
31. Mascart F., Hainaut M., Peltier A., Verscheure V., Levy J., Locht C. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 2007, 25(2):391-398.
32. Berrington J.E., Cant A.J., Matthews J.N.S., O'Keeffe M., Spickett G.P., Fenton A.C. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose. Pediatrics 2006, 117(4):e717-e724.
33. Sikora J.P., Chlebna-Sokół D., Ligenza I., Sikora A. Haemophilus influenzae type b and pertussis vaccinations in preterm infants. Arch Immunol Ther Exp 2006, 54(3):193-199.